CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 327 enrolled
Drug / intervention
no specific treatmentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02002091
NCT02002091N/ACompleted
CompareCT.gov

Prevalence of Micro and Macroangiopathy in Newly Diagnosed type2 Diabetic Adults in Suburban Area of Algiers

University of Algiers·observational·Posted Dec 5, 2013·Updated Jun 21, 2024

In Brief

An observational study evaluating no specific treatment for Type2 Diabetes Mellitus and Complications. Completed, enrolled 327 participants across 1 site.

Detailed Summary

* It is a prospective,observational, cohort study * The main purpose of the study is to assess the prevalence of diabetic chronic complications in newly diagnosed type 2 diabetics in suburban area of Algiers. * The secondary purpose is to study the impact of diabetic renal complications as a risk factor on the atherothrombotic events.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType2 Diabetes Mellitus, Complications
CountriesAlgeria
CollaboratorsNational Institute of public Health, Algeria, Hopital Ain Taya, Parnet Hospital, Hôpital Mustapha Pacha, Birtraria Hospital, Bab El Oued Teaching Hospital

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 5, 2013
Enrollment StartJan 1, 2009
Primary CompletionDec 1, 2013
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 12.6 years ago

Interventions

no specific treatmentother

lifestyle counseling, antihypertensive drugs, antidiabetic drugs (oral and / or insulin)treatment of comorbidity or complications of diabetes.